Medicinal Cannabis and CBD in Mental Healthcare

Author:   Kylie O'Brien ,  Philip Blair
Publisher:   Springer Nature Switzerland AG
Edition:   1st ed. 2021
ISBN:  

9783030785581


Pages:   576
Publication Date:   28 October 2021
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $258.72 Quantity:  
Add to Cart

Share |

Medicinal Cannabis and CBD in Mental Healthcare


Add your own review!

Overview

Full Product Details

Author:   Kylie O'Brien ,  Philip Blair
Publisher:   Springer Nature Switzerland AG
Imprint:   Springer Nature Switzerland AG
Edition:   1st ed. 2021
Weight:   1.114kg
ISBN:  

9783030785581


ISBN 10:   3030785580
Pages:   576
Publication Date:   28 October 2021
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Introduction Endocannabinoid system: will cover what the endocannabinoid system is, the concept of endocannabinoid deficiency Overview of cannabis: will cover what is cannabis, historical use in mental health, active constituents with a focus on CBD (but also including THC, terpenes) Pharmacokinetics and Safety: including potential toxicity, recreational cannabis vs medicinal uses, drug-herb interactions Stress and Anxiety: will cover how CBD can reduce anxiety (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study (1-2). Depression: will cover how CBD can reduce depression (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study. Sleep disorders: will cover how CBD can be used to treat insomnia and sleep apnoea (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study. PTSD: will cover how CBD can be used to treat PTSD (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study Co-morbid chronic pain and mental health: will cover how CBD can be used to treat chronic pain and co-morbid mental health issues- sleep and depression, and the scientific evidence for efficacy. It will also include guidance on dosing, and 2 case studies. Dementia: will cover the evidence for its efficacy in treating dementia including Alzheimer’s Disease. ADHD, Autism End of life and existential matters- the role of cannabis including CBD Conclusion: will cover a holistic approach to treatment of mental health that includes cannabis then conclude the book.

Reviews

Author Information

Professor Kylie O’Brien PhDKylie O’Brien PhD Adjunct Professor Torrens University Director of Research & Education International College of Cannabinoid Medicine Email: kylie@iccm.co Phone: +61 412 077689 Dr Philip Blair, MDDr. Philip Blair, MD, Colonel (US Army Ret) CEO of AbleDoc, Inc, International Medical Consultant Chief Medical Officer, International College of Cannabinoid Medicine Chief Medical Officer, Releaf Clinics, Australia Chief Science Officer for Harvest 360 Castle Rock, Washington email: abledoc@mac.com

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

Aorrng

Shopping Cart
Your cart is empty
Shopping cart
Mailing List